Security Snapshot

Personalis, Inc. - Common Stock, $0.0001 par value per share (PSNL) Institutional Ownership

CUSIP: 71535D106

13F Institutional Holders and Ownership History from Q2 2019 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

139

Shares (Excl. Options)

84,584,455

Price

$6.37

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+3,324,109
Value change
+$18,994,834
Number of holders
139
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
104,548,584
SEC-reported price per share
$5.78
Insider filing price
$5.78
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • PSNL - Personalis, Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 71535D106.
  • 139 institutions reported positions in Q1 2026.
  • 10 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 125 to 139 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $644,778,177 to $538,766,734.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 139 institutions filings for Q1 2026.

Open SEC evidence

Security key

71535D106

Latest holder period

Q1 2026

13F holders

139

13D/G owners

10

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
10
Security
PSNL
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Merck & Co., Inc. 16% $53,792,132 14,044,943 Merck & Co., Inc. 19 Dec 2024
Tempus AI, Inc. 14% $58,553,040 12,868,800 Eric Lefkofsky 11 Sep 2025
KEYWELL BRADLEY A 7.6% $49,211,559 12,848,971 Bradley A. Keywell 17 Jan 2025
Red Sky Ventures LLC 4.7% -17% $52,546,773 -$9,366,221 8,059,321 -15% Red Sky Ventures LLC 30 Sep 2025
ARK Investment Management LLC 8.1% -14% $27,530,795 +$1,580,878 7,188,197 +6.1% ARK Investment Management LLC 31 Mar 2025
AMERIPRISE FINANCIAL INC 7.1% $53,880,884 6,287,151 Ameriprise Financial, Inc. 31 Dec 2025
Deep Track Capital, LP 5.5% $36,349,556 5,760,627 Deep Track Capital, LP 05 May 2026
T. Rowe Price Investment Management, Inc. 4.5% -63% $30,312,846 -$38,366,225 4,758,091 -56% T. Rowe Price Investment Management, Inc. 31 Mar 2026
HIRSCHMAN ORIN 3.8% -38% $27,205,633 -$6,982,468 3,416,720 -20% Orin Hirschman 31 Dec 2025
BlackRock, Inc. 3.5% $11,318,301 2,955,170 BlackRock, Inc. 31 Dec 2024

As of 31 Mar 2026, 139 institutional investors reported holding 84,584,455 shares of Personalis, Inc. - Common Stock, $0.0001 par value per share (PSNL). This represents 81% of the company’s total 104,548,584 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
72%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Merck & Co., Inc. 13% 14,044,943 0% 26% $89,466,287
LIGHTSPEED MANAGEMENT COMPANY, L.L.C. 7.8% 8,160,734 0% 5.3% $51,983,876
ARK Investment Management LLC 7.6% 7,944,112 +0.83% 0.39% $50,603,993
AMERIPRISE FINANCIAL INC 7.3% 7,592,807 +21% 0.01% $48,366,193
BlackRock, Inc. 5.2% 5,389,885 +1.3% 0% $34,333,567
T. Rowe Price Investment Management, Inc. 4.6% 4,758,091 -56% 0.02% $30,310,000
Aberdeen Group plc 3.3% 3,488,308 +7.3% 0.04% $22,220,522
Deep Track Capital, LP 2.9% 3,000,000 0.39% $19,110,000
AIGH Capital Management LLC 2.8% 2,900,000 0% 3.8% $18,473,000
VANGUARD CAPITAL MANAGEMENT LLC 2.7% 2,868,463 0% 0% $18,272,109
KENNEDY CAPITAL MANAGEMENT LLC 2.1% 2,183,572 +27% 0.29% $13,909,354
Blue Water Life Science Advisors, LP 1.6% 1,676,300 0% 8.6% $10,678,031
PRICE T ROWE ASSOCIATES INC /MD/ 1.6% 1,650,141 +14% 0% $10,513,000
Casdin Capital, LLC 1.5% 1,600,000 0.77% $10,192,000
GEODE CAPITAL MANAGEMENT, LLC 1.2% 1,297,655 -0.01% 0% $8,268,159
STATE STREET CORP 1.1% 1,134,170 +8% 0% $7,224,663
DIMENSIONAL FUND ADVISORS LP 1% 1,066,248 +8.4% 0% $6,790,741
PFM Health Sciences, LP 0.83% 870,097 +8% 0.58% $5,542,518
GOLDMAN SACHS GROUP INC 0.71% 737,132 +115% 0% $4,695,531
Portolan Capital Management, LLC 0.7% 736,713 +94% 0.25% $4,692,862
JPMORGAN CHASE & CO 0.55% 575,490 +2054% 0% $3,591,057
VANGUARD PORTFOLIO MANAGEMENT LLC 0.54% 560,539 0% 0% $3,570,633
HOWLAND CAPITAL MANAGEMENT LLC 0.52% 547,115 0% 0.14% $3,485,123
STATE OF MICHIGAN RETIREMENT SYSTEM 0.47% 493,798 0% 0.02% $3,145,493
Sumitomo Mitsui Trust Group, Inc. 0.46% 484,270 -6.6% 0% $3,084,800

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
28
Latest
Q1 2026
Rows shown
1-25 of 28
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 84,584,455 $538,766,734 +$18,994,834 $6.37 139
2025 Q4 81,001,611 $644,778,177 +$129,305,525 $7.96 125
2025 Q3 64,702,482 $421,838,154 +$27,589,778 $6.52 107
2025 Q2 60,456,657 $396,611,525 +$44,202,043 $6.56 105
2025 Q1 54,828,320 $192,441,316 +$10,090,223 $3.51 102
2024 Q4 51,601,342 $298,243,551 -$3,572,926 $5.78 107
2024 Q3 29,319,270 $161,516,207 +$43,033,654 $5.38 83
2024 Q2 21,956,574 $25,689,907 -$438,121 $1.17 69
2024 Q1 22,271,019 $33,182,519 +$217,168 $1.49 70
2023 Q4 21,963,535 $46,098,090 -$4,605,029 $2.10 68
2023 Q3 24,787,157 $29,989,246 -$2,223,907 $1.21 63
2023 Q2 26,077,892 $48,999,684 -$2,366,338 $1.88 64
2023 Q1 27,192,343 $74,996,760 +$205,499 $2.76 62
2022 Q4 27,801,895 $55,045,447 -$1,904,858 $1.98 78
2022 Q3 28,367,717 $83,900,229 -$5,226,601 $2.97 77
2022 Q2 29,874,257 $105,564,934 -$15,549,124 $3.45 95
2022 Q1 32,474,275 $265,328,914 -$398,164 $8.19 120
2021 Q4 32,151,998 $456,199,133 +$2,045,734 $14.27 105
2021 Q3 31,406,739 $604,224,567 -$14,422,392 $19.24 116
2021 Q2 31,940,492 $807,886,761 +$23,454,157 $25.30 132
2021 Q1 30,722,882 $755,704,555 +$60,986,103 $24.61 130
2020 Q4 26,591,341 $973,697,818 +$110,231,063 $36.61 128
2020 Q3 25,391,300 $552,000,648 +$128,507,444 $21.67 90
2020 Q2 18,853,701 $244,721,982 +$7,255,056 $12.97 77
2020 Q1 19,072,243 $153,524,384 +$10,223,267 $8.07 65
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .